Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a confirmed malignant tumour of the pancreatic ducts (confirmed by laboratory testing of tissue)
- People with pancreatic cancer that can be surgically removed and are receiving chemotherapy and radiation before surgery, OR people with locally advanced pancreatic cancer that cannot be surgically removed and are receiving chemotherapy and radiation as a primary or preparatory treatment
- People who have been assessed as being at nutritional risk, based on two specific nutritional screening tools (NRS2002 score of 3 or higher, and a moderate nutritional status rating on a tool called PG-SGA) (confirm with trial site)
- People aged 18 years or older
- People whose general physical functioning is rated as fully active or restricted in strenuous activity only, based on a standard medical scale (ECOG score of 0 or 1)
- People whose life expectancy is estimated to be more than 3 months
- People who have previously received some form of cancer treatment
Who may not be able to join:
- People with a known allergy or intolerance to any ingredient in the oral nutritional supplement being studied
- People who have used the type of oral nutritional supplement being studied within the month before enrolling
- People whose tumour is pressing on a specific part of the digestive system (the major duodenal papilla), or who have jaundice or acute pancreatitis
- People with medical conditions that make cancer treatment unsafe, such as coronary heart disease, stroke, brain bleed, or other serious illnesses
- People with liver, kidney, or blood clotting problems that indicate organ failure
- People with blood disorders
- People with active infections
- People who have another unrelated primary cancer
- People with other medical conditions that are seriously affecting their nutritional health
- People who the trial investigator considers unsuitable for the trial for other reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Weiwei Xiao, Sun Yat-sen University
Phone: +86 020 8734 0951
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence rate of grade 3 or higher acute toxicity related to neoadjuvant chemoradiotherapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.